Follow-The-Filings

INMB INmune Bio

INmune Bio earnings company data as of 4:47 AM ET 9/7

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period · newest first · EPS & Rev stacked · nothing reported yet

Period Date Metric Estimate Actual Result
FY2026 Q3 29 Oct EPS
Rev

SEC filings

Recent issuer filings from EDGAR · 23 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
10-Q QUARTERLY REPORT
8-K 8.01,9.01
8-K 1.01,9.01
8-K 8.01,9.01
8-K 5.02,5.07,9.01
8-K 8.01,9.01
8-K 8.01,9.01
10-Q QUARTERLY REPORT
8-K 1.01,7.01,9.01
10-K ANNUAL REPORT
8-K 7.01,9.01
8-K 8.01,9.01
8-K 8.01,9.01
8-K 7.01,9.01
8-K 7.01,9.01
8-K 1.01,9.01
424B5 PROSPECTUS SUPPLEMENT
8-K 1.01,9.01
8-K 1.02
8-K 1.01,3.03,9.01
8-K 8.01,9.01
8-K 5.02,9.01
8-K 5.02,9.01

Insider forms

Form 3 / 4 / 5 from EDGAR · 2 rows shown

Filed Form Detail Links
4 Period Jul 2, 2026 · 3 forms
4 Period Dec 1, 2025 · 2 forms

12 more insider forms →

Consensus estimates · SEC filings remain the official record · not investment advice